lidocaine has been researched along with Peripheral Nervous System Neoplasms in 1 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Peripheral Nervous System Neoplasms: Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devor, M | 1 |
Wall, PD | 1 |
Catalan, N | 1 |
1 other study available for lidocaine and Peripheral Nervous System Neoplasms
Article | Year |
---|---|
Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction.
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Ganglia, Spinal; Lidocaine; Male; Nerv | 1992 |